Pharma-bio Serv Inc (PBSV) financial statements (2020 and earlier)

Company profile

Business Address INDUSTRIAL ZONE STREET 1
DORADO, 00646
State of Incorp.
Fiscal Year End October 31
SIC 8742 - Management Consulting Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2020
TTM
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
10/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15,25515,49016,07411,77813,79414,92715,156
Cash and cash equivalents15,25515,49016,03011,75213,77414,89315,088
Short-term investments  4427203368
Receivables7,71710,0316,9437,2086,8537,4486,386
Other current assets 454394550981892783
Other undisclosed current assets1,661      
Total current assets:24,63225,97523,41219,53721,62823,26722,325
Noncurrent Assets
Operating lease, right-of-use asset908 
Property, plant and equipment2522912982,3912,334854869
Long-term investments and receivables  1,250    
Accounts and financing receivable, after allowance for credit loss  1,250    
Other noncurrent assets368367418423361817
Total noncurrent assets:1,5286581,9672,8132,370872886
TOTAL ASSETS:26,16026,63325,37822,35023,99824,13923,211
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,3851,5902,1401,5272,0912,0622,355
Taxes payable2,27034441224539249
Interest and dividends payable 1,725     
Other undisclosed accounts payable and accrued liabilities(885)(479)1,7281,5252,0462,0232,106
Debt154111414232322
Other undisclosed current liabilities4082,06941224539249
Total current liabilities:1,9463,6712,5661,5432,1592,1242,626
Noncurrent Liabilities
Long-term debt and lease obligation729674660295275
Capital lease obligations674660295275
Operating lease, liability729 
Liabilities, other than long-term debt 2,2882,503    
Accounts payable and accrued liabilities 2,2702,485    
Other liabilities 1818    
Other undisclosed noncurrent liabilities2,352      
Total noncurrent liabilities:3,0822,3552,54960295275
Total liabilities:5,0286,0265,1151,6032,1882,1762,700
Stockholders' equity
Stockholders' equity attributable to parent21,13220,60820,26420,74721,81021,96320,511
Common stock2222222
Treasury stock, value(394)(393)(305)(248)(233)(187)(18)
Additional paid in capital1,3931,3811,3471,2951,2311,1431,055
Accumulated other comprehensive income (loss)132144108138(166)(227)(136)
Retained earnings20,00019,47319,11119,56020,97521,23219,607
Total stockholders' equity:21,13220,60820,26420,74721,81021,96320,511
TOTAL LIABILITIES AND EQUITY:26,16026,63325,37822,35023,99824,13923,211

Income statement (P&L) ($ in thousands)

1/31/2020
TTM
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
10/31/2014
Revenues19,55419,50717,79715,57919,53723,38527,555
Revenue, net15,57919,53723,38527,555
Cost of revenue(13,270)(13,330)(12,111)(11,968)(13,753)(15,900)(18,582)
Cost of goods and services sold   (11,968)(13,753)(15,900)(18,582)
Gross profit:6,2836,1775,6873,6115,7837,4848,973
Operating expenses(4,435)(4,433)(4,593)(5,036)(5,875)(5,703)(6,093)
Other undisclosed operating income (loss)333343(2,356)   (16)
Operating income (loss):2,1822,087(1,262)(1,425)(92)1,7812,864
Nonoperating income (expense)49152743614(57)1114
Investment income, nonoperating    (55)195
Interest and debt expense     (7)(7)
Income (loss) from continuing operations before equity method investments, income taxes:2,6722,614(826)(1,411)(149)1,7852,871
Other undisclosed income (loss) from continuing operations before income taxes(381)(391)2,350 (55)77
Income (loss) from continuing operations before income taxes:2,2912,2231,524(1,411)(204)1,7932,878
Income tax expense(148)(136)(2,786)(4)(53)(168)(465)
Income (loss) from continuing operations:2,1432,087(1,262)(1,415)(257)1,6252,414
Income from discontinued operations  2,541    
Net income (loss) available to common stockholders, diluted:2,1432,0871,280(1,415)(257)1,6252,414

Comprehensive Income ($ in thousands)

1/31/2020
TTM
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
10/31/2014
Net income (loss):2,1432,0871,280(1,415)(257)1,6252,414
Comprehensive income (loss):2,1432,0871,280(1,415)(257)1,6252,414
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1636(30)30461(91)(59)
Comprehensive income (loss), net of tax, attributable to parent:2,1592,1231,250(1,111)(196)1,5342,355

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: